Clinical Studies on FARMA T.E.B. and Trimprob
We are committed to innovation in medical diagnostics and support this with numerous studies. Review the results of clinical studies that confirm the effectiveness of our systems.
Trimprob Research
Trimprob is a portable system for early non-invasive diagnosis of various types of cancer. The system uses electromagnetic waves to distinguish between normal and pathological tissues.
Clinical Results
- Prostate Cancer DiagnosisStudies have shown that Trimprob has high sensitivity (86-95%) and specificity (43-63%) in diagnosing prostate cancer, confirming its reliability and accuracy.
- Diagnosis of Other Types of CancerTrimprob is also successfully used for detecting bladder, breast, thyroid, and stomach cancers. Research has confirmed the device's high diagnostic accuracy in all these cases.
Testing Procedure
The patient stands approximately 2 meters away from the receiver, while the operator conducts the scan using a handheld probe. The system detects changes in electromagnetic waves when interacting with pathological tissues, allowing for the identification of abnormalities.
Examples of Use
Trimprob has proven its effectiveness in diagnosing cancer in thousands of patients worldwide, demonstrating high reliability and ease of use.
Research on Farma T.E.B.
Farma T.E.B. is an innovative system for transdermal drug delivery, used in various medical fields including urology, gynecology, and dermatology.
Clinical Results
- Effectiveness OverviewFarma T.E.B. has demonstrated high effectiveness in accelerating tissue healing by more than 3 times compared to traditional methods. The system delivers active substances to a depth of up to 10-12 cm through the skin, promoting rapid and effective treatment.
- Use in Clinical PracticeFarma T.E.B. is used for treating a wide range of diseases due to its safety and versatility. The system does not cause tissue damage and does not penetrate the systemic bloodstream, making it ideal for various medical fields. The procedures using Farma T.E.B. are quick to perform, allowing for rapid results and the initiation of treatment.
Our systems have undergone numerous studies and have been recognized in the medical community. Scientific publications and conferences confirm the high effectiveness and reliability of our technologies.
- 5000+Patients Successfully Diagnosed Using Trimprob
- 95%Cases - such a percentage of studies have confirmed its high accuracy and reliability
- 97%The tests have shown high diagnostic accuracy and the ability to detect genetic anomalies using a minimal amount of DNA samples.